The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementing clinical-scale multiscale spatial transcriptomics: Tumor architecture profiling in SCRUM-Japan MONSTAR-SCREEN-3.
 
Mitsuho Imai
Consulting or Advisory Role - Exact Sciences
Speakers' Bureau - 10X Genomics; Caris Life Sciences; Chugai Pharma; Exact Sciences
Research Funding - Exact Sciences
Patents, Royalties, Other Intellectual Property - 1. ?NCC's Reference: #2023-03 Filing number (Filing date): US 63/468,666 (2023.05.24) Title: METHOD OF USING AN ARTIFICIAL INTELLIGENCE-POWERED WHOLE SLIDE IMAGE (WSI) ANALYSIS TO PREDICT TUMOR RESPONSE TO SUBSEQUENT IMMUNE CHECKPOINT INHIBITOR TREATMEN
 
Eun Seop Seo
Employment - GxD
 
Jiyeon Hyeon
Employment - GxD
 
Shingo Sakashita
Consulting or Advisory Role - Chugai Pharma
Speakers' Bureau - DAIICHI SANKYO COMPANY, LIMITED (I)
 
Junichiro Yuda
Research Funding - Abbvie; Amgen; AstraZeneca; Brighpath Bio; Bristol-Myers Squibb/Celgene; Celeid Therapeutics; Chugai Pharma; Daiichi Sankyo; Genmab; Incyte; Janssen; Mitsubishi Tanabe; MSD; Novartis; Sanofi; Sumitomo Pharma; Takeda
 
Yuka Nakamura
No Relationships to Disclose
 
Tadayoshi Hashimoto
Honoraria - Cytogen; Guardant Health; Miyarisan pharmaceutical; Myriad Genetics; Takata Pharmaceutical
Consulting or Advisory Role - Guardant Health
 
Shin Kobayashi
Honoraria - Merck KGaA; Ono Pharmaceutical
 
Riu Yamashita
Consulting or Advisory Role - Takeda
 
Taro Shibuki
Honoraria - AstraZeneca; Exact Sciences; Novartis
Research Funding - LabCorp (Inst)
 
Takao Fujisawa
Honoraria - Amelief; AstraZeneca; Merck; Merck Serono
 
Masataka Amisaki
No Relationships to Disclose
 
Kensuke Matsuda
Consulting or Advisory Role - AbbVie
Speakers' Bureau - Chugai, Kyowa Kirin
 
Shun-ichiro Kageyama
No Relationships to Disclose
 
Michiko Nagamine
Honoraria - GxD, Inc; Matsunami Glass Ind.,Ltd.; SRL Diagnostics
 
Takeshi Kuwata
Honoraria - Agilent; Amgen; Astellas Pharma; Bristol-Myers Squibb Japan; Daiichi Sankyo; FALCO biosystems; Guardant Health; MSD; Myriad Genetics; Roche; SRL Diagnostics
Consulting or Advisory Role - Agilent; Amgen; Astellas Pharma; BeOne; Daiichi Sankyo; GxD; MSD; Roche
Research Funding - Takeda
 
Hideaki Bando
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
 
Woong-Yang Park
Leadership - GxD.Inc
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Indivumed; Sumitomo Corp.
Research Funding - Bristol-Myers Squibb Japan (Inst); Caris MPI (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); Exact Sciences (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Miyarisan pharmaceutical (Inst); MSD (Inst); Natera (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)